Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Youyong, Lv"'
Publikováno v:
OncoTargets and Therapy. 12:2531-2538
In this study, we present the case of a 56-year-old patient with renal clear cell carcinoma who developed lung metastases 13 months after nephrectomy and subsequently received tyrosine kinase inhibitor (sunitinib) and PD-1 antibody (nivolumab) immuno
Autor:
Zhi Guo, Qiang Wang, Jun Wang, Jing Liang, Mingxin He, Qi Xie, Qingming Wu, Guanxin Shen, Baoli Zhu, Jun Yu, Li Yu, Xiaohua Tan, Lanlan Wei, Jun Ren, Youyong Lv, Lijuan Deng, Qian Yin, Hao Zhou, Wei Wu, Min Zhang, Wenyan Yang, Mingqiang Qiao, Rong Shu, Zhongjun Xia, Zhiming Li, Ziming Huang, Weiguo Hu, Liang Wang, Zhi Liu, Guoliang Pi, Hua Ren, Yong Ji, Zhe Liu, Xiaofei Qi, Peng Chen, Liang Shao, Feng Chen, Xiaojun Xu, Weiqing Chen, null Tumor and Microecology
Publikováno v:
Journal of Cancer Research and Therapeutics. 18:1835
Autor:
Xiangyang Xue, Lizhi Niu, Kecheng Xu, Youyong Lv, Lihua He, Mao Lin, Shuzhen Liang, Jibing Chen, Yin-Xiong Li, Lifang Zhang
Publikováno v:
Oncotarget
Aberrantly expressed microRNAs contribute to the initiation and progression of human cancer. MiRNA-187 has been reported in nasopharyngeal, renal, pancreatic, prostate, and esophageal cancer, and acts as a tumor suppressor or oncogene. However, the u
'Real world survey' of hydrogen-controlled cancer: a follow-up report of 82 advanced cancer patients
Autor:
Jibing Chen, Shu-Cun Qin, Kecheng Xu, Tian-Yu Lu, Xiao-Feng Kong, Feng Mu, Youyong Lv, Xue-Jun Sun
Publikováno v:
Medical Gas Research
Advanced cancer treatment is a huge challenge and new ideas and strategies are required. Hydrogen exerts antioxidant and anti-inflammatory effects that may be exploited to control cancer, the occurrence and progression of which is closely related to
Autor:
Lizhi Niu, Kecheng Xu, Mao Lin, Jiongyuan Xu, Shuzhen Liang, Yong Hu, Youyong Lv, Zhu Weibing, Qian Wei, Zhanchun Zhou, Jibing Chen, Feng Jiang
Publikováno v:
Immunology letters. 183
Dendritic cells (DCs) and cytokine-induced killer (CIK) cells have both shown activity as immunotherapy in some malignancies. Our aim was to prospective assess the effect of this immunotherapy in patients with stage IV breast cancer. Between Aug 2003
Autor:
Yuanzi, Yu, Wenji, Yan, Xuefeng, Liu, Yan, Jia, Baoping, Cao, Yingyan, Yu, Youyong, Lv, Malcolm V, Brock, Jame G, Herman, Julien, Licchesi, Yunsheng, Yang, Mingzhou, Guo
Publikováno v:
American journal of cancer research. 4(6)
Dapper, Dishevelled-associated antagonist of β-catenin (DACT), is a key regulator of Wnt signaling pathway. The purpose of this study is to explore the epigenetic changes and the function ofDACT2 in human gastric cancer (GC). Eight human gastric can
Publikováno v:
Theoretical Biology & Medical Modelling
Theoretical Biology and Medical Modelling, Vol 9, Iss 1, p 53 (2012)
Theoretical Biology and Medical Modelling, Vol 9, Iss 1, p 53 (2012)
Background To analyze the p42.3 gene expression in gastric cancer (GC) cell, find the relationship between protein structure and function, establish the regulatory network of p42.3 protein molecule and then to obtain the optimal regulatory pathway. M
Autor:
Youyong Lv, Rui Xing
Publikováno v:
Journal of Translational Medicine, Vol 10, Iss Suppl 2, p A11 (2012)
Journal of Translational Medicine
Journal of Translational Medicine
Our data show that these genes are involved in several well-studied signaling pathways associated with development and progression of GC. Our results indicated that alterations of MMP11, MT2A, p42.3, Cyr61 and GKN1 at mRNA and protein level were cons
Publikováno v:
European journal of pharmacology. 700(1-3)
The highly toxic monomer 12-deoxyphorbol 13-palmitate (G) was extracted from the roots of Euphorbia fischeriana. Our experimental data confirmed studies showing that 12-deoxyphorbol 13-palmitate had certain antitumor activities. The MTT method, soft
Autor:
Youyong Lv
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 10, Iss Suppl 2, p A51 (2012)
Journal of Translational Medicine, Vol 10, Iss Suppl 2, p A51 (2012)
Cancer is the first cause of death in China. Approximately 1.6 million people died of cancer and more than 2.2 millions of new cases were diagnosed each year. In order to reveal the puzzle of genomic alterations and biology of human cancers, the new-